DiscoveryLab: making molecular medicine
This is an open forum for researchers to explore how best to work together to discover and develop new targets and lead molecules.
We offer a space for collaboration and partnering focused on designing novel therapeutic agents based on the precise mechanisms of genetic disorders, cancer and infectious diseases.
DiscoveryLab was initiated by Michael Overduin and coworkers with a grant from the John R. Evans Leaders Fund awarded by the Canada Foundation for Innovation, Alberta Innovates, Department of Economic Development and Trade, and the Province of Alberta.
The funding was announced at NANUC by the Minister of Science Kirsty Duncan on March 14, 2016. The press included the CBC, Edmonton Journal and Sun, iNews, University of Alberta and Global News.
- building trust and mutual understanding to ensure sustainable and rewarding multi-party relationships in mechanism-based drug discovery,
- identifying major challenges that require innovative thinking including tackling unexploited target types,
- mapping out precompetitive spaces for open-source collaboration and harmonization of standards,
- developing fair and reasonable intellectual property strategies for progression and scalable funding,
- structuring and optimizing core activities and facilities for delivery of milestone-driven projects, and
- increasing data quality, reproducibility and decisiveness while eliminating unnecessary duplication and costs.
We welcome academic collaborators and industry partners.
Department of Biochemistry
Faculty of Medicine & Dentistry
Funded by a John R. Evans Leaders Fund Award